Global Cell and Gene Therapy Drug Delivery Devices Market Research Report 2024(Status and Outlook)
Report Overview
Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.
This report provides a deep insight into the global Cell and Gene Therapy Drug Delivery Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy Drug Delivery Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy Drug Delivery Devices market in any manner.
Global Cell and Gene Therapy Drug Delivery Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation
Market Segmentation (by Type)
Sterile Insulin Syringe
Pre-Filled Syringe
Infusion Bags
Market Segmentation (by Application)
Luxturna
Kymriah
Provenge
Zolgensma
Yescarta
Strimvelis
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy Drug Delivery Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.
This report provides a deep insight into the global Cell and Gene Therapy Drug Delivery Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy Drug Delivery Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy Drug Delivery Devices market in any manner.
Global Cell and Gene Therapy Drug Delivery Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation
Market Segmentation (by Type)
Sterile Insulin Syringe
Pre-Filled Syringe
Infusion Bags
Market Segmentation (by Application)
Luxturna
Kymriah
Provenge
Zolgensma
Yescarta
Strimvelis
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell and Gene Therapy Drug Delivery Devices Market
- Overview of the regional outlook of the Cell and Gene Therapy Drug Delivery Devices Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy Drug Delivery Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Drug Delivery Devices
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy Drug Delivery Devices Segment by Type
1.2.2 Cell and Gene Therapy Drug Delivery Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell and Gene Therapy Drug Delivery Devices Sales by Manufacturers (2019-2024)
3.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell and Gene Therapy Drug Delivery Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell and Gene Therapy Drug Delivery Devices Sales Sites, Area Served, Product Type
3.6 Cell and Gene Therapy Drug Delivery Devices Market Competitive Situation and Trends
3.6.1 Cell and Gene Therapy Drug Delivery Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell and Gene Therapy Drug Delivery Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY DRUG DELIVERY DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Cell and Gene Therapy Drug Delivery Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2019-2024)
6.3 Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2019-2024)
6.4 Global Cell and Gene Therapy Drug Delivery Devices Price by Type (2019-2024)
7 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy Drug Delivery Devices Market Sales by Application (2019-2024)
7.3 Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Cell and Gene Therapy Drug Delivery Devices Sales Growth Rate by Application (2019-2024)
8 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET SEGMENTATION BY REGION
8.1 Global Cell and Gene Therapy Drug Delivery Devices Sales by Region
8.1.1 Global Cell and Gene Therapy Drug Delivery Devices Sales by Region
8.1.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Cell and Gene Therapy Drug Delivery Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell and Gene Therapy Drug Delivery Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Amgen, Inc.
9.1.1 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.1.2 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.1.4 Amgen, Inc. Business Overview
9.1.5 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
9.1.6 Amgen, Inc. Recent Developments
9.2 Bausch and Lomb Incorporated
9.2.1 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Basic Information
9.2.2 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Overview
9.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.2.4 Bausch and Lomb Incorporated Business Overview
9.2.5 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
9.2.6 Bausch and Lomb Incorporated Recent Developments
9.3 Becton, Dickinson and Company
9.3.1 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Basic Information
9.3.2 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Overview
9.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
9.3.5 Becton, Dickinson and Company Business Overview
9.3.6 Becton, Dickinson and Company Recent Developments
9.4 Bluebird bio, Inc.
9.4.1 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.4.2 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.4.4 Bluebird bio, Inc. Business Overview
9.4.5 Bluebird bio, Inc. Recent Developments
9.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
9.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Basic Information
9.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Overview
9.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
9.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
9.6 Dendreon Pharmaceuticals LLC.
9.6.1 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.6.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.6.4 Dendreon Pharmaceuticals LLC. Business Overview
9.6.5 Dendreon Pharmaceuticals LLC. Recent Developments
9.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
9.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Basic Information
9.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Overview
9.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
9.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
9.8 Human Stem Cell Institute
9.8.1 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Basic Information
9.8.2 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Overview
9.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.8.4 Human Stem Cell Institute Business Overview
9.8.5 Human Stem Cell Institute Recent Developments
9.9 Kite Pharma, Inc.
9.9.1 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.9.2 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.9.4 Kite Pharma, Inc. Business Overview
9.9.5 Kite Pharma, Inc. Recent Developments
9.10 Kolon Tissue Gene, inc.
9.10.1 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.10.2 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.10.4 Kolon Tissue Gene, inc. Business Overview
9.10.5 Kolon Tissue Gene, inc. Recent Developments
9.11 Novartis AG
9.11.1 Novartis AG Cell and Gene Therapy Drug Delivery Devices Basic Information
9.11.2 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Overview
9.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.11.4 Novartis AG Business Overview
9.11.5 Novartis AG Recent Developments
9.12 Orchard Therapeutics plc.
9.12.1 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.12.2 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.12.4 Orchard Therapeutics plc. Business Overview
9.12.5 Orchard Therapeutics plc. Recent Developments
9.13 Pfizer, Inc.
9.13.1 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.13.2 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.13.4 Pfizer, Inc. Business Overview
9.13.5 Pfizer, Inc. Recent Developments
9.14 Renova Therapeutics
9.14.1 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Basic Information
9.14.2 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Overview
9.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.14.4 Renova Therapeutics Business Overview
9.14.5 Renova Therapeutics Recent Developments
9.15 Spark Therapeutics, Inc.
9.15.1 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.15.2 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.15.4 Spark Therapeutics, Inc. Business Overview
9.15.5 Spark Therapeutics, Inc. Recent Developments
9.16 uniQure N.V.
9.16.1 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.16.2 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.16.4 uniQure N.V. Business Overview
9.16.5 uniQure N.V. Recent Developments
9.17 Vericel Corporation
9.17.1 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Basic Information
9.17.2 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Overview
9.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.17.4 Vericel Corporation Business Overview
9.17.5 Vericel Corporation Recent Developments
10 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET FORECAST BY REGION
10.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast
10.2 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
10.2.3 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Region
10.2.4 South America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy Drug Delivery Devices by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell and Gene Therapy Drug Delivery Devices by Type (2025-2030)
11.1.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell and Gene Therapy Drug Delivery Devices by Type (2025-2030)
11.2 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Application (2025-2030)
11.2.1 Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) Forecast by Application
11.2.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Drug Delivery Devices
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy Drug Delivery Devices Segment by Type
1.2.2 Cell and Gene Therapy Drug Delivery Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell and Gene Therapy Drug Delivery Devices Sales by Manufacturers (2019-2024)
3.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell and Gene Therapy Drug Delivery Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell and Gene Therapy Drug Delivery Devices Sales Sites, Area Served, Product Type
3.6 Cell and Gene Therapy Drug Delivery Devices Market Competitive Situation and Trends
3.6.1 Cell and Gene Therapy Drug Delivery Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell and Gene Therapy Drug Delivery Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY DRUG DELIVERY DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Cell and Gene Therapy Drug Delivery Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2019-2024)
6.3 Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2019-2024)
6.4 Global Cell and Gene Therapy Drug Delivery Devices Price by Type (2019-2024)
7 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy Drug Delivery Devices Market Sales by Application (2019-2024)
7.3 Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Cell and Gene Therapy Drug Delivery Devices Sales Growth Rate by Application (2019-2024)
8 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET SEGMENTATION BY REGION
8.1 Global Cell and Gene Therapy Drug Delivery Devices Sales by Region
8.1.1 Global Cell and Gene Therapy Drug Delivery Devices Sales by Region
8.1.2 Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Cell and Gene Therapy Drug Delivery Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell and Gene Therapy Drug Delivery Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Amgen, Inc.
9.1.1 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.1.2 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.1.4 Amgen, Inc. Business Overview
9.1.5 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
9.1.6 Amgen, Inc. Recent Developments
9.2 Bausch and Lomb Incorporated
9.2.1 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Basic Information
9.2.2 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Overview
9.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.2.4 Bausch and Lomb Incorporated Business Overview
9.2.5 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
9.2.6 Bausch and Lomb Incorporated Recent Developments
9.3 Becton, Dickinson and Company
9.3.1 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Basic Information
9.3.2 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Overview
9.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
9.3.5 Becton, Dickinson and Company Business Overview
9.3.6 Becton, Dickinson and Company Recent Developments
9.4 Bluebird bio, Inc.
9.4.1 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.4.2 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.4.4 Bluebird bio, Inc. Business Overview
9.4.5 Bluebird bio, Inc. Recent Developments
9.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
9.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Basic Information
9.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Overview
9.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
9.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
9.6 Dendreon Pharmaceuticals LLC.
9.6.1 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.6.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.6.4 Dendreon Pharmaceuticals LLC. Business Overview
9.6.5 Dendreon Pharmaceuticals LLC. Recent Developments
9.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
9.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Basic Information
9.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Overview
9.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
9.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
9.8 Human Stem Cell Institute
9.8.1 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Basic Information
9.8.2 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Overview
9.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.8.4 Human Stem Cell Institute Business Overview
9.8.5 Human Stem Cell Institute Recent Developments
9.9 Kite Pharma, Inc.
9.9.1 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.9.2 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.9.4 Kite Pharma, Inc. Business Overview
9.9.5 Kite Pharma, Inc. Recent Developments
9.10 Kolon Tissue Gene, inc.
9.10.1 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.10.2 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.10.4 Kolon Tissue Gene, inc. Business Overview
9.10.5 Kolon Tissue Gene, inc. Recent Developments
9.11 Novartis AG
9.11.1 Novartis AG Cell and Gene Therapy Drug Delivery Devices Basic Information
9.11.2 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Overview
9.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.11.4 Novartis AG Business Overview
9.11.5 Novartis AG Recent Developments
9.12 Orchard Therapeutics plc.
9.12.1 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.12.2 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.12.4 Orchard Therapeutics plc. Business Overview
9.12.5 Orchard Therapeutics plc. Recent Developments
9.13 Pfizer, Inc.
9.13.1 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.13.2 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.13.4 Pfizer, Inc. Business Overview
9.13.5 Pfizer, Inc. Recent Developments
9.14 Renova Therapeutics
9.14.1 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Basic Information
9.14.2 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Overview
9.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.14.4 Renova Therapeutics Business Overview
9.14.5 Renova Therapeutics Recent Developments
9.15 Spark Therapeutics, Inc.
9.15.1 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.15.2 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.15.4 Spark Therapeutics, Inc. Business Overview
9.15.5 Spark Therapeutics, Inc. Recent Developments
9.16 uniQure N.V.
9.16.1 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Basic Information
9.16.2 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Overview
9.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.16.4 uniQure N.V. Business Overview
9.16.5 uniQure N.V. Recent Developments
9.17 Vericel Corporation
9.17.1 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Basic Information
9.17.2 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Overview
9.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Market Performance
9.17.4 Vericel Corporation Business Overview
9.17.5 Vericel Corporation Recent Developments
10 CELL AND GENE THERAPY DRUG DELIVERY DEVICES MARKET FORECAST BY REGION
10.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast
10.2 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
10.2.3 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Region
10.2.4 South America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy Drug Delivery Devices by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell and Gene Therapy Drug Delivery Devices by Type (2025-2030)
11.1.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell and Gene Therapy Drug Delivery Devices by Type (2025-2030)
11.2 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Application (2025-2030)
11.2.1 Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) Forecast by Application
11.2.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy Drug Delivery Devices Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell and Gene Therapy Drug Delivery Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2022)
Table 10. Global Market Cell and Gene Therapy Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell and Gene Therapy Drug Delivery Devices Sales Sites and Area Served
Table 12. Manufacturers Cell and Gene Therapy Drug Delivery Devices Product Type
Table 13. Global Cell and Gene Therapy Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell and Gene Therapy Drug Delivery Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy Drug Delivery Devices Market Challenges
Table 22. Global Cell and Gene Therapy Drug Delivery Devices Sales by Type (K Units)
Table 23. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (M USD)
Table 24. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2019-2024)
Table 26. Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell and Gene Therapy Drug Delivery Devices Market Size Share by Type (2019-2024)
Table 28. Global Cell and Gene Therapy Drug Delivery Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) by Application
Table 30. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application
Table 31. Global Cell and Gene Therapy Drug Delivery Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2019-2024)
Table 33. Global Cell and Gene Therapy Drug Delivery Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2019-2024)
Table 35. Global Cell and Gene Therapy Drug Delivery Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell and Gene Therapy Drug Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region (2019-2024)
Table 38. North America Cell and Gene Therapy Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell and Gene Therapy Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell and Gene Therapy Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 43. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 44. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 45. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Amgen, Inc. Business Overview
Table 47. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
Table 48. Amgen, Inc. Recent Developments
Table 49. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 50. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 51. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bausch and Lomb Incorporated Business Overview
Table 53. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
Table 54. Bausch and Lomb Incorporated Recent Developments
Table 55. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 56. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 57. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
Table 59. Becton, Dickinson and Company Business Overview
Table 60. Becton, Dickinson and Company Recent Developments
Table 61. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 62. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 63. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bluebird bio, Inc. Business Overview
Table 65. Bluebird bio, Inc. Recent Developments
Table 66. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 67. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 68. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
Table 70. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
Table 71. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 72. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 73. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Dendreon Pharmaceuticals LLC. Business Overview
Table 75. Dendreon Pharmaceuticals LLC. Recent Developments
Table 76. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 77. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 78. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
Table 80. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
Table 81. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 82. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 83. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Human Stem Cell Institute Business Overview
Table 85. Human Stem Cell Institute Recent Developments
Table 86. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 87. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 88. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Kite Pharma, Inc. Business Overview
Table 90. Kite Pharma, Inc. Recent Developments
Table 91. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 92. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 93. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Kolon Tissue Gene, inc. Business Overview
Table 95. Kolon Tissue Gene, inc. Recent Developments
Table 96. Novartis AG Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 97. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 98. Novartis AG Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Novartis AG Business Overview
Table 100. Novartis AG Recent Developments
Table 101. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 102. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 103. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Orchard Therapeutics plc. Business Overview
Table 105. Orchard Therapeutics plc. Recent Developments
Table 106. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 107. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 108. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Pfizer, Inc. Business Overview
Table 110. Pfizer, Inc. Recent Developments
Table 111. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 112. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 113. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Renova Therapeutics Business Overview
Table 115. Renova Therapeutics Recent Developments
Table 116. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 117. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 118. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Spark Therapeutics, Inc. Business Overview
Table 120. Spark Therapeutics, Inc. Recent Developments
Table 121. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 122. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 123. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. uniQure N.V. Business Overview
Table 125. uniQure N.V. Recent Developments
Table 126. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 127. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 128. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Vericel Corporation Business Overview
Table 130. Vericel Corporation Recent Developments
Table 131. Global Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Cell and Gene Therapy Drug Delivery Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy Drug Delivery Devices Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell and Gene Therapy Drug Delivery Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2022)
Table 10. Global Market Cell and Gene Therapy Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell and Gene Therapy Drug Delivery Devices Sales Sites and Area Served
Table 12. Manufacturers Cell and Gene Therapy Drug Delivery Devices Product Type
Table 13. Global Cell and Gene Therapy Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell and Gene Therapy Drug Delivery Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy Drug Delivery Devices Market Challenges
Table 22. Global Cell and Gene Therapy Drug Delivery Devices Sales by Type (K Units)
Table 23. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (M USD)
Table 24. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2019-2024)
Table 26. Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell and Gene Therapy Drug Delivery Devices Market Size Share by Type (2019-2024)
Table 28. Global Cell and Gene Therapy Drug Delivery Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) by Application
Table 30. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application
Table 31. Global Cell and Gene Therapy Drug Delivery Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2019-2024)
Table 33. Global Cell and Gene Therapy Drug Delivery Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2019-2024)
Table 35. Global Cell and Gene Therapy Drug Delivery Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell and Gene Therapy Drug Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region (2019-2024)
Table 38. North America Cell and Gene Therapy Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell and Gene Therapy Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell and Gene Therapy Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 43. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 44. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 45. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Amgen, Inc. Business Overview
Table 47. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
Table 48. Amgen, Inc. Recent Developments
Table 49. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 50. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 51. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bausch and Lomb Incorporated Business Overview
Table 53. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
Table 54. Bausch and Lomb Incorporated Recent Developments
Table 55. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 56. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 57. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices SWOT Analysis
Table 59. Becton, Dickinson and Company Business Overview
Table 60. Becton, Dickinson and Company Recent Developments
Table 61. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 62. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 63. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bluebird bio, Inc. Business Overview
Table 65. Bluebird bio, Inc. Recent Developments
Table 66. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 67. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 68. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
Table 70. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
Table 71. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 72. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 73. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Dendreon Pharmaceuticals LLC. Business Overview
Table 75. Dendreon Pharmaceuticals LLC. Recent Developments
Table 76. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 77. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 78. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
Table 80. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
Table 81. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 82. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 83. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Human Stem Cell Institute Business Overview
Table 85. Human Stem Cell Institute Recent Developments
Table 86. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 87. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 88. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Kite Pharma, Inc. Business Overview
Table 90. Kite Pharma, Inc. Recent Developments
Table 91. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 92. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 93. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Kolon Tissue Gene, inc. Business Overview
Table 95. Kolon Tissue Gene, inc. Recent Developments
Table 96. Novartis AG Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 97. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 98. Novartis AG Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Novartis AG Business Overview
Table 100. Novartis AG Recent Developments
Table 101. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 102. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 103. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Orchard Therapeutics plc. Business Overview
Table 105. Orchard Therapeutics plc. Recent Developments
Table 106. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 107. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 108. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Pfizer, Inc. Business Overview
Table 110. Pfizer, Inc. Recent Developments
Table 111. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 112. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 113. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Renova Therapeutics Business Overview
Table 115. Renova Therapeutics Recent Developments
Table 116. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 117. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 118. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Spark Therapeutics, Inc. Business Overview
Table 120. Spark Therapeutics, Inc. Recent Developments
Table 121. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 122. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 123. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. uniQure N.V. Business Overview
Table 125. uniQure N.V. Recent Developments
Table 126. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Basic Information
Table 127. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Overview
Table 128. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Vericel Corporation Business Overview
Table 130. Vericel Corporation Recent Developments
Table 131. Global Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Cell and Gene Therapy Drug Delivery Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell and Gene Therapy Drug Delivery Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD), 2019-2030
Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) (2019-2030)
Figure 6. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy Drug Delivery Devices Market Size by Country (M USD)
Figure 11. Cell and Gene Therapy Drug Delivery Devices Sales Share by Manufacturers in 2023
Figure 12. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Manufacturers in 2023
Figure 13. Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell and Gene Therapy Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Type
Figure 18. Sales Market Share of Cell and Gene Therapy Drug Delivery Devices by Type (2019-2024)
Figure 19. Sales Market Share of Cell and Gene Therapy Drug Delivery Devices by Type in 2023
Figure 20. Market Size Share of Cell and Gene Therapy Drug Delivery Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Cell and Gene Therapy Drug Delivery Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application
Figure 24. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application in 2023
Figure 26. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2019-2024)
Figure 27. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application in 2023
Figure 28. Global Cell and Gene Therapy Drug Delivery Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Country in 2023
Figure 32. U.S. Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell and Gene Therapy Drug Delivery Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell and Gene Therapy Drug Delivery Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Country in 2023
Figure 37. Germany Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region in 2023
Figure 44. China Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (K Units)
Figure 50. South America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Country in 2023
Figure 51. Brazil Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Application (2025-2030)
Figure 66. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Cell and Gene Therapy Drug Delivery Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD), 2019-2030
Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size (M USD) (2019-2030)
Figure 6. Global Cell and Gene Therapy Drug Delivery Devices Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy Drug Delivery Devices Market Size by Country (M USD)
Figure 11. Cell and Gene Therapy Drug Delivery Devices Sales Share by Manufacturers in 2023
Figure 12. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Manufacturers in 2023
Figure 13. Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell and Gene Therapy Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Type
Figure 18. Sales Market Share of Cell and Gene Therapy Drug Delivery Devices by Type (2019-2024)
Figure 19. Sales Market Share of Cell and Gene Therapy Drug Delivery Devices by Type in 2023
Figure 20. Market Size Share of Cell and Gene Therapy Drug Delivery Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Cell and Gene Therapy Drug Delivery Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application
Figure 24. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application in 2023
Figure 26. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2019-2024)
Figure 27. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application in 2023
Figure 28. Global Cell and Gene Therapy Drug Delivery Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Country in 2023
Figure 32. U.S. Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell and Gene Therapy Drug Delivery Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell and Gene Therapy Drug Delivery Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Country in 2023
Figure 37. Germany Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region in 2023
Figure 44. China Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (K Units)
Figure 50. South America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Country in 2023
Figure 51. Brazil Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell and Gene Therapy Drug Delivery Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell and Gene Therapy Drug Delivery Devices Sales Forecast by Application (2025-2030)
Figure 66. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Application (2025-2030)
